Our vision is that all Irish patients can afford and access the medicines they need to get well, stay well and live well.


Total spend on medicine in 2015 by the HSE was €2 billion – the largest single spend in our health service.


In terms of health expenditure per capita, Ireland ranks as the 8th highest spend amongst selected OECD countries.


Life expectancy in Ireland has increased by almost two and a half years since 2005 and has been consistently higher than the EU average throughout the last decade.

Who we are

About us

The way Ireland procures and supplies medicines is outdated and no longer fit for purpose.

Medicines for Ireland is an organisation founded and motivated by a strong desire to fix this problem.

Globally and in Ireland, the presumption of automatic access to innovative medicines is no longer guaranteed. The supply of medicines requires radical reform so that patients can access life-saving and life-enhancing treatment vital to their well-being.

Achieving reform in this critical area of patient care is a core objective of our organisation.

We are committed to working with key stakeholders to affect real change and reforms that ensure Irish patients receive the best medical treatment in the most affordable way.

Leadership

Padraic O’Brien, Chairperson of Medicines for Ireland

Managing Director, Accord Healthcare Ireland

Director of Medicines for Ireland

Padraic is Managing Director at Accord Healthcare Ireland. He is a native of Monaghan and a graduate of DIT and Trinity College Dublin and has held a number of senior management positions within Accord, most recently as Commercial Director where he has overseen the implementation of the Accord Sales Strategy.

 

Paul Neill, Vice-Chairperson of Medicines for Ireland

Director of Generic Medicines, Teva Pharmaceuticals Ireland

Director of Medicines for Ireland

Paul is the Director of Generic Medicines for Teva Pharmaceuticals Ireland, the largest supplier of prescription medicines to the State. Paul brings with him a wealth of practical experience gained from almost twenty years in various commercial roles in the Pharmaceutical Market – ten of these in leadership roles in Teva.

 

Committees

Sarah O’Neill, Chair of the Regulatory Committee

Group Technical Director, DCC Vital / Fannin Limited

Sarah is Group Technical Director for DCC Vital and has over 25 years of experience in the healthcare industry in a variety of roles including sales, marketing and technical functions. Sarah is responsible for Quality, Regulatory and EHS for medicines, medical devices and associated services across the DCC Vital group of companies including Fannin Limited.

 

Clodagh Kevans, Chair of Value Added Medicines Committee

Director of Specialty Medicines, Teva Pharmaceuticals Ireland

A graduate of Trinity College Dublin and UCD Smurfit Business School Clodagh leads the Specialty business for Teva Pharmaceuticals in Ireland, the largest supplier of prescription medicines to the State. Clodagh has a depth of experience built up from over twenty years in the Pharmaceutical Industry. She has been a member of the Leadership Team for Teva Pharmaceuticals Ireland for the past 10 years.

 

Paul Williams, Chair of the Communications Committee

Senior Director of Corporate Affairs, Teva

Paul Williams has worked in the generics industry for nearly 20 years at Teva. He is a public affairs specialist and had senior roles in the UK and the Netherlands, before becoming Teva’s Corporate Affairs head for Ireland and the UK in 2019. He has been Chair of the Communications Committee since its inception.

 

Anna Daly, Chair of Finance Committee

Accounts Assistant, Rowa/Rowex Pharmaceuticals Ltd.

Anna works as an Accounts Assistant at Rowa/Rowex Pharmaceuticals Ltd.  She recently received her Diploma in Management Accounting and is working towards achieving the Chartered Institute of Management Accounting (CIMA) qualification.  She is also a BComm (Hons) graduate of UCC

 

Melissa Fisher, Chair of Generics Committee

General Manager at Viatris

Melissa joined the pharma landscape in Ireland 14 years ago, where she held numerous roles across Finance and Commercial. Prior to this she owned a retail business, while also providing supply chain consultancy services to multi nationals in Ireland. Melissa is a graduate of The University of Johannesburg and Technical University Dublin.

 

David Delaney, Chair of EU Affairs Committee

Head of Policy & Market Access in Europe NW at Viatris

David is head of Policy and Market Access Europe NW at Viatris and Co-Founder and Board member of Medicines for Ireland. He leads advocacy at the European Parliament and Trade Committees for MFI and as a Board member of Medicines for Europe. David helps  manage the MFI relationship with Ireland’s Department of Health, other Government Departments, regulators and media on key industry related matters.

 

Michael Comerford, Chair of Biosimilars Committee

Commercial Director at Celltrion

Michael is Commercial Director at Celltrion Healthcare and chair of the Biosimilars committee. He has over 25 years managing products and leading teams across various therapeutic disciplines and has been working with biosimilars since 2014. He established Celltrion Healthcare in Ireland and is responsible for the strategic management of their expanding biosimilar portfolio.

 

Members

Accord Healthcare

Celltrion Healthcare

Clonmel Healthcare

Consilient Health

Fannin Ltd

Fresenius Kabi

Nasal Medical

Pinewood Healthcare

Rowa Pharmaceuticals

Teva

Viatris

 

Supporters

Uniphar

4045 Kingwood Road, Citywest Business Park, Co. Dublin D24 VO6K

Tel: +353 1 428 7777

 

United Drug

Unit 10, Magna Drive, Citywest Road, Magna Business Park, Dublin 24 D24 XKE5

Tel: +353 1 463 2300

 

 

 

 

 

 

News

Publications

Contact

Medicines for Ireland,

13 Merrion Square,

Dublin 2

D02 HW89

info@medicinesforireland.ie

Medicines for Ireland, 13 Merrion Square, Dublin 2 D02 HW89